Targeting the oxytocin receptor to relax the myometrium

Bibliography

• RAMSAY DJ: Posterior pituitary gland. In: Basic & Clinical Endocrinology, Greenspann FS, Forsham PH (Eds.), Los Altos, CA Lange, (1983):120-129.
   Google Scholar
• CHARD T, HUDSON CN, EDWARDS CRW, BOYD NHR: Release of oxytocin and vasopressin by the human foetus during labour. Nature (1971) 234:352-354.
   PubMed Web of Science ®Google Scholar
• BLANKS A, ALLEN MJ, THORNTON S: Human myometrium contains immunoreactive arginine vasopressin before and after the onset of labour. J. Soc. Gynecol. Invest. (2000) 7:223a.
   Google Scholar
• CHIBBAR R, MILLER FD, MITCHELL BF: Synthesis of oxytocin in amnion, chorion and decidua may influence the timing of human parturition. J. Clin. Invest. (1993) 91:185-192.
   PubMed Web of Science ®Google Scholar
• STEINWALL M, HANSSON S, BOSSMAR T, LARSSON I, PILKA R, ÅKERLUND M: Oxytocin mRNA content in the endometrium of non-pregnant women. Br. J. Obstet. Gynaecol. (2004) 111:266-270.
   Google Scholar
• FUCHS AR, FUCH F, SOLOFT MS: Oxytocin receptors in nonpregnant human uterus. J. Clin. Endocrinol. Metab. (1985) 60:37-41.
   PubMedGoogle Scholar
• KIMURA T, TANIZAWA O, MORI K, BROWNSTEIN MJ, OKAYAMA H: Structure and expression of a human oxytocin receptor. Nature (1992) 356:526-529.
   PubMed Web of Science ®Google Scholar
• IVELL R, KIMURA T, MULLER D et al.: The structure and regulation of the oxytocin receptor. Exp. Physiol. (2001) 86:289-296.
   PubMedGoogle Scholar
• THIBONNIER M, AUZAN C, MADHUN Z, WILKINS P, BERTI-MATTERA L, CLAUSER E: Molecular cloning, sequencing and functional expression of a cDNA encoding the human V1a vasopressin receptor. J. Biol. Chem. (1994) 269:3304-3310.
   PubMed Web of Science ®Google Scholar
• MAGGI M, DEL CARLO P, FANTONI G et al.: Human myometrium during pregnancy contains and respond to V1a VP receptors as well as oxytocin receptors. J. Clin. Endocrinol. Metab. (1990) 70:1142-1154.
   PubMed Web of Science ®Google Scholar
• BOSSMAR T, ÅKERLUND M, FANTONI G, SZAMATOWICZ J, MELIN P, MAGGI M: Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy. Effects of the oxytocin antagonist atosiban. Am. J. Obstet. Gynecol. (1994) 171:1634-1642.
   PubMed Web of Science ®Google Scholar
• REZAPOUR M, BACKSTROM T, ULMSTEN U: Myometrial steroid concentration and oxytocin receptor density in parturient women at term. Steroids. (1996) 61:338-344.
   PubMedGoogle Scholar
• WATHES DC, BORWICK SC, TIMMONS PM, LEUNG ST, THORNTON S: Oxytocin receptor expression in human term and preterm gestational tissues prior to and following the onset of labour. J. Endocrinol. (1999) 161:143-151.
   PubMed Web of Science ®Google Scholar
• TERZIDOU V, SOORANNA SR, KIM LU, THORNTON S, BENNETT PR, JOHNSON MR: Mechanical stretch up-regulates the human oxytocin receptor in primary human uterine myocytes. J. Clin. Endocrinol. Metab. (2005) 90:237-246.
   PubMed Web of Science ®Google Scholar
• GERMAIN AM, KATO S, CARVAJAL JA, VALENZUELA GJ, VALDES GL, GLASINOVIC JC: Bile acids increase response and expression of human myometrial oxytocin receptor. Am. J. Obstet. Gynecol. (2003) 189:577-582.
   PubMed Web of Science ®Google Scholar
• ÅKERLUND M, BOSSMAR T, BROUARD R et al.: Receptor binding of oxytocin and vasopressin antagonists and inhibitory effects on isolated myometrium from preterm and term pregnant women. Br. J. Obstet. Gynaecol. (1999) 106:1047-1053.
   PubMedGoogle Scholar
• ROBINSON C, SCHUMANN R, ZHANG P, YOUNG RC: Oxytocin-induced desensitization of the oxytocin receptor. Am. J. Obstet. Gynecol. (2003) 188:497-502.
   PubMed Web of Science ®Google Scholar
• PHANEUF S, RODRIGUEZ LINARES B, TAMBYRAJA RL, MACKENZIE IZ, LOPES BERNAL A: Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour. J. Reprod. Fertil. (2000) 120:91-97.
   PubMedGoogle Scholar
• PHANEUF S, ASBOTH G, CARRASCO MP et al.: The desensitization of oxytocin receptors in human myometrial cells is accompanied by down-regulation of oxytocin receptor messenger RNA. J. Endocrinol. (1997) 154:7-18.
   PubMed Web of Science ®Google Scholar
• MAGGI M, PERI A, BALDI E, MANCINA R et al.: Interferon-alpha downregulates expression of the oxytocin receptor in cultured human myometrial cells. Am. J. Physiol. (1996) 271:E840-E846.
   PubMedGoogle Scholar
• LEAKE RD, WEITZMANN RE, GLATZ TH, FISHER DA: Plasma oxytocin concentrations in men, non-pregnant women, and pregnant women before and during spontaneous labor. J. Clin. Endocrinol. Metab. (1981) 53:730-733.
   PubMed Web of Science ®Google Scholar
• FUCHS AR, ROMERO R, KEEFE D, PARRA M, OYARZUNE BEHNKE E: Oxytocin secretion and human parturition: Pulse frequency and duration increased during spontaneous labour in women. Am. J. Obstet. Gynecol. (1991) 165:1515-1523.
   PubMed Web of Science ®Google Scholar
• THORNTON SS, DAVIDSON JM, BAYLIS PH: Plasma oxytocin during the first and second stages of spontaneous human labour. Acta Endocrinol. (1992) 126:425-429.
   PubMedGoogle Scholar
• FUCHS AR, BEHRENS O, LIU HC: Correlation of nocturnal increase in plasma oxytocin with a decrease in plasma estradiol/progesterone ratio in late pregnancy. Am. J. Obstet. Gynecol. (1992) 167:159-163.
   Google Scholar
• CHARD T: Oxytocin. In: Clinical Neuroendocrinology, Martini L, Bessre GM (Eds.), New York: Academic Press (1977):569-583.
   Google Scholar
• SCHILD HO, FIZPATRICK RJ, NIXON WCW: Activity of the human cervix and corpus uteri; their response to drugs in early pregnancy. Lancet (1951) 1:250-253.
   PubMedGoogle Scholar
• FUCHS AR, FUCHS F, HUSSLEIN P, SOLOFF MS: Oxytocin receptors in the human uterus during pregnancy and parturition. Am. J. Obstet. Gynecol. (1984) 150:734-741.
   PubMed Web of Science ®Google Scholar
• KIMURA T, TAKEMURA M, NOMURA S et al.: Expression of oxytocin receptor in human pregnant myometrium. Endocrinol. (1996) 137:780-785.
   PubMed Web of Science ®Google Scholar
• WILSON RJ, ALLEN MJ, NANDI M, GILES H, THORNTON S: Spontaneous contractions of myometrium from humans, non-human primate and rodents are sensitive to selective oxytocin receptor antagonism in vitro. Br. J. Obstet. Gynaecol. (2001) 108:960-966.
   Google Scholar
• ÅKERLUND M, STRÖMBERG P, HAUKSON A et al.: Inhibition of uterine contraction of premature labour with an oxytocin analogue. Results from a pilot study. Br. J. Obstet. Gynaecol. (1987) 94:1040-1044.
   PubMedGoogle Scholar
• GOODWIN TM, PAUL R, SILVER H et al.: The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am. J. Obstet. Gynecol. (1994) 170:474-478.
   PubMed Web of Science ®Google Scholar
• WORLDWIDE ATOSIBAN VERSUS β-AGONIST STUDY GROUP: An analysis of the pooled data from three randomised double-blind controlled trials of the oxytocin antagonist atosiban versus the β-adrenergic agonists ritodrine, terbutaline and salbutamol in the treatment of preterm labour. Br. J. Obstet. Gynaecol. (2001) 108:133-142.
   Google Scholar
• STEINWALL M, BOSSMAR T, BROUARD R et al.: The effect of relcovaptan (SR 49059), an orally active vasopressin V1a receptor antagonist, on uterine contractions in preterm labour. Gynecol. Endocrinol. (2005) 20:104-109.
   PubMed Web of Science ®Google Scholar
• BOSSMAR T, RASMUSSEN T, ÅKERLUND M: Effect of the non-peptide, vasopressin V1a receptor antagonist, SR 49059, and its enantiomer SR 49770, on isolated human myometrium. Acta. Obstet. Gynecol. Scand. (1996) 76:516-519.
   Google Scholar
• STEINWALL M, BOSSMAR T, GAUD C, ÅKERLUND M: Inhibitory effects of SR 49059 on oxytocin- and vasopressin-induced contractions in non-pregnant women. Acta Obstet. Gynecol. Scand. (2004) 83:12-18.
   PubMed Web of Science ®Google Scholar
• NILSSON L, REINHEIMER T, STEINWALL M, ÅKERLUND M: FE 200 440, an oxytocin analogue which selectively and potently inhibits oxytocin receptor mediated human uterine contractions. Br. J. Obstet. Gynaecol. (2003) 110:1025-1028.
   Google Scholar
• PIERZYNSKI P, LEMANCEWICZ A, REINHEIMER T, ÅKERLUND M, LAUDANSKI T: Inhibitory effect of barusiban and atosiban on oxytocin-induced contractions of myometrium from preterm and term pregnant women. Int. Soc. Gynecol. Invest. (2004) 11:384-387.
   PubMedGoogle Scholar
• MANNING M, CHENG LL, STOEV S et al.: Design of peptide oxytocin antagonists with strikingly higher affinities and selectivities for the human oxytocin receptor than atosiban. J. Peptide. Sci. (2005) 11:593-608.
   PubMed Web of Science ®Google Scholar
• QUATTROPANI A, DORBAIS J, COVINI D et al.: Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists. J. Med. Chem. (2005) 48:7882-7905.
   PubMed Web of Science ®Google Scholar
• STYMIEST JL, MITCHELL BF, WONG S, VEDERAS JC: Synthesis of oxytocin analogues with replacement of sulphur by carbon gives potent antagonists with increased stability. J. Org. Chem. (2005) 70:7799-7809.
   PubMed Web of Science ®Google Scholar
• PAPATSONIS D, FLENADY V, COLE S, LILEY H: Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst. Rev. (2005) 3:CD004452.
   PubMedGoogle Scholar
• PAPATSONIS DNM, FLENADY VJ, DEKKER GA, CARBONNE B, KING JF: Response to ‘The drug we deserve’. Br. J. Obstet. Gynaecol. (2004) 111:1025.
   Google Scholar
• BOSSMAR T, ÅKERLUND M, FANTONI G, MAGGI M, SZAMATOWICZ J, LAUDANSKI T: Receptor-mediated uterine effects of oxytocin and vasopressin in non-pregnant women. Br. J. Obstet. Gynaecol. (1995) 102:907-912.
   PubMedGoogle Scholar
• FUCHS AR, BEHRENS O, MASCHEK H, KUPSCH E, EINSPANIER A: Oxytocin and vasopressin receptors in human and uterine myomas during menstrual cycle and early pregnancy. Hum. Reprod. Update (1998) 4:594-604.
   PubMedGoogle Scholar
• RICHARDS S, ZING MM: The human oxytocin gene promotor is regulated by estrogens. J. Biol. Chem. (1990) 265:6052-6103.
   Google Scholar
• TAKEMURA M, NOMIUZ S, KIMURA T et al.: Expression and localization of human oxytocin receptor gene in human uterine endometrium in relation to menstrual cycle. Endocrinol. (1993) 132:1830-1835.
   PubMedGoogle Scholar
• HELMER H, HACKL T, SCHNEEBERGER C et al.: Oxytocin and vasopressin V1a receptor gene expression in the cycling or pregnant human uterus. Am. J. Obstet. Gynecol. (1999) 179:1572-1578.
   Google Scholar
• ÅKERLUND M, ANDERSSON K-E, INGEMARSSON I: Effects of terbutaline on myometrial activity, endomtrial blood flow and lower abdominal pain in women with primary dysmenorrhoea. Br. J. Obstet. Gynaecol. (1976) 83:673-678.
   PubMedGoogle Scholar
• ÅKERLUND M, STRÖMBERG P, FORSLING ML: Primary dysmenorrhoea and vasopressin. Br. J. Obstet. Gynaecol. (1979) 86:484-487.
   PubMedGoogle Scholar
• EKSTRÖM P, LAUDANSKI T, MRUGACZ G, FORSLING M, KINDAHL H, ÅKERLUND M: Stimulation of vasopressin release in women with primary dysmenorrheoa and after oral contraceptive treatment – effect on uterine contractility. Br. J. Obstet. Gynaecol. (1992) 99:680-684.
   PubMedGoogle Scholar
• STRÖMBERG P, ÅKERLUND M, FORSLING ML, GRANSTRÖM E, KINDAHL H: Vasopressin and prostaglandin in premenstrual pain and primary dysmenorrhoea. Acta Obstet. Gynaecol. Scand. (1984) 63:533-538.
   PubMed Web of Science ®Google Scholar
• CHAN WY, WO NC, STOEV ST, CHENG LL, MANNING M: Discovery and design of novel and selective vasopressin and oxytocin agonists and antagonists: the role of bioassays. Exp. Physiol. (2000) 85:7S-18S.
   Google Scholar
• ÅKERLUND M: Can primary dysmenorrhoea be alleviated by a vasopressin antagonist? Results of a pilot study. Acta. Obstet. Gynecol. Scand. (1987) 66:459-461.
   PubMed Web of Science ®Google Scholar
• BROUARD R, BOSSMAR T, FOURNIÉ-LLORET D, CHASSARD D, ÅKERLUND M: Effects of SR 49059, an orally active vasopressin V1a receptor antagonist, in the prevention of dysmenorrhoea. Br. J. Obstet. Gynaecol. (2000) 107:614-618.
   Google Scholar
• LIEDMAN R, GRANT L, IGIDBASHIAN S et al.: Intrauterine pressure, ischemia markers and experienced pain during administration of a vasopressin V1a receptor antagonist in spontaneous and vasopressin-induced dysmenorrhoea. Acta. Obstet. Gynecol. Scand. (2005) 85:451-457.
   Google Scholar